Review: The World of the Crow Indians: As Driftwood Lodges by Rodney Frey
In: Explorations in Ethnic Studies, Band ESS-8, Heft 1, S. 24-25
ISSN: 2576-2915
11 Ergebnisse
Sortierung:
In: Explorations in Ethnic Studies, Band ESS-8, Heft 1, S. 24-25
ISSN: 2576-2915
In: Explorations in Ethnic Studies, Band ESS-7, Heft 1, S. 19-19
ISSN: 2576-2915
In: Explorations in Ethnic Studies, Band ESS-5, Heft 1, S. 83-84
ISSN: 2576-2915
In: Explorations in Ethnic Studies, Band ESS-4, Heft 1, S. 56-57
ISSN: 2576-2915
In: Explorations in Ethnic Studies, Band ESS-3, Heft 1, S. 30-31
ISSN: 2576-2915
In: Special care in dentistry: SCD, Band 13, Heft 2, S. 74-80
ISSN: 1754-4505
The number of recipients of liver transplants has grown rapidly in the last few years and is likely to continue to do so in the future. The dentist should be prepared to see individuals who are contemplating or have had liver transplants.The major goal of dental intervention, before and after liver transplantation, is the prevention of bacteremia from an oral source that could lead to systemic infection. In addition, pre‐transplant medical conditions of concern to the dentist include poor drug metabolism, bleeding disorders, poor wound healing, and an inability to metabolize swallowed blood. Post‐transplant dental treatment must take into consideration immunosuppressive drugs and the potential for infections.Dental treatment should include a thorough dental examination, elimination of dental problems that could cause medical problems, and an intensive preventive dentistry program to minimize the occurrence of dental disease.
Multiple studies have shown a high prevalence of chronic hepatitis B (CHB) infection in the Philippines, not only in high-risk populations but also in the general population. The most recent national study estimated HBsAg seroprevalence to be 16.7%, corresponding to an estimated 7.3 million CHB adults. The factors underlying the high prevalence of CHB and its sequelae include the inadequate use of vaccination for prevention and the lack of treatment for many Filipinos. Because without medical monitoring and treatment of CHB the risk of progression to liver failure and death is 25-30%, the ultimate medical and societal costs will be very high if the Philippines fails to properly address hepatitis B infection. It will be very important to move forward with programs that can help to ensure universal vaccination of newborns, screening and vaccination nationwide, and monitoring and treatment for CHB persons. It will also be crucial to address transmission of HBV in the health-care setting (via contaminated needles and syringes and inadequately sterilized hospital equipment) and via injection drug use and tattooing. Because of the relatively low average per capita income and the lack of coverage by PhilHealth of outpatient visits and medications, there is an urgent need to move forward with a nationally supported program that includes education for both the general public and health-care workers on liver disease and screening for hepatitis viruses, followed by, as appropriate, vaccination or treatment, with expanded government coverage for these for all those who could not otherwise afford it.
BASE
BACKGROUND AND AIMS: Although prevalence of chronic hepatitis B (CHB) in the USA includes 0.42 million (range, 0.28‐0.67) U.S.‐born persons, foreign‐born (FB) persons contribute a substantially larger number to the burden of CHB in the USA. Over the past decade, patterns of U.S. immigration have changed and many countries have implemented HBV prevention programs. This study aims to estimate the number of FB persons with CHB in the USA by country of origin, updating our 2011 study. APPROACH AND RESULTS: We performed systematic searches for articles published in 2009–2019 reporting HBsAg seroprevalence in emigrants and in‐country populations of 117 countries. Data meeting inclusion criteria were combined with data from our 2011 study to calculate pooled prevalence estimates for 99 countries using meta‐analyses (total 2,800 surveys involving 112 million subjects). Combining country‐specific CHB rate estimates with the number of FB in the USA in 2018, by country of origin from the U.S. Census Bureau, we estimate that the number of FB with CHB in the USA in 2018 was 1.47 million (95% CI, 1.21‐1.73), substantially higher than previously reported. The weighted average CHB prevalence for all FB in the USA in 2018 was 3.07%. Approximately 59% of FB with CHB in the USA in 2018 emigrated from Asia, 19% from the Americas, and 15% from Africa. Subgroup analyses found that for many countries, CHB rates are higher in males than females and have declined over the past three decades, but no consistent pattern is observed between emigrant and in‐country rates. CONCLUSIONS: Including FB and U.S.‐born persons, the total prevalence of CHB in the USA may be as high as 2.4 million.
BASE
In: American Indian Culture and Research Journal, Band 11, Heft 3, S. 93-133
In: American Indian Culture and Research Journal, Band 12, Heft 3, S. 85-143
In: American Indian Culture and Research Journal, Band 10, Heft 3, S. 71-136